Cabergoline and mitral valve sclerosis Patient Reports February 12, 2012

Cabergoline Side Effects Report #5082036-3
Cabergoline side effect was reported by a Physician from GERMANY on Aug 01, 2006. Male patient, 54 years of age, weighting 154.3 lb, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic arteriosclerosis, asthenia, dilatation ventricular, ejection fraction decreased, mitral valve incompetence, mitral valve sclerosis. Cabergoline dosage: 1 MG (1 IN 1 D), ORAL. During the same period patient was treated with CARVEDILOL, DIOVAN HCT, SPIRONOLACTONE, ZOCOR, TORSEMIDE. Patient recovered.

Cabergoline Side Effects Report #5502491-1
Cabergoline side effect was reported by a Physician from GERMANY on Oct 18, 2007. Female patient, weighting 132.3 lb, was diagnosed with parkinsonism and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, left ventricular dysfunction, mitral valve incompetence, mitral valve sclerosis, tricuspid valve incompetence. Cabergoline dosage: DAILY DOSE:10MG. Patient recovered.

Cabergoline Side Effects Report #5608635-5
Cabergoline side effect was reported by a Consumer or non-health professional from GERMANY on Jan 20, 2008. Female patient, 75 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac arrest , cardiogenic shock, chest pain , dyspnoea, hypotension, mitral valve incompetence, mitral valve sclerosis. Cabergoline dosage: DAILY DOSE:4MG. Patient was hospitalized. Patient died.

Cabergoline Side Effects Report #5094396-8
Cabergoline side effect was reported by a Physician from DENMARK on Aug 16, 2006. Male patient, 73 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, dyspnoea, mitral valve incompetence, mitral valve sclerosis, pleural fibrosis. Cabergoline dosage: 6 MG (DAILY), ORAL. During the same period patient was treated with CORODIL, COMTESS, SINEMET. Patient recovered.


Cabergoline Side Effects Report #4688270-6
Cabergoline side effect was reported by a Physician from on May 27, 2005. Male patient, 73 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, cardiac valve disease, dyspnoea, fibrosis, mitral valve incompetence, mitral valve sclerosis, pleural fibrosis. Cabergoline dosage: 6 MG (DAILY), ORAL. During the same period patient was treated with CORODIL, COMTESS, SINEMET. Patient recovered.

Cabergoline Side Effects Report #4700637-6
Cabergoline side effect was reported by a Physician from on June 14, 2005. Female patient, 68 years of age, weighting 143.3 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, mitral valve sclerosis. Cabergoline dosage: MAXIMAL 2MG (DAILY); ORAL. During the same period patient was treated with AMANTADINE, MADOPAR. Patient recovered.

Cabergoline Side Effects Report #4987994-0
Cabergoline side effect was reported by a Consumer or non-health professional from DENMARK on Apr 19, 2006. Male patient, 58 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure, cardiac procedure complication, mitral valve incompetence, mitral valve sclerosis, tricuspid valve incompetence, tricuspid valve sclerosis. Cabergoline dosage: 6 MG (6 MG, 1 D), ORAL. During the same period patient was treated with SINEMET, ELDEPRYL, SIMVASTATIN, ODRIK, SPIRONOLACTONE, CORDARONE, FUROSEMIDE, DIMITONE. Patient was hospitalized and became disabled. Patient recovered.

Cabergoline Side Effects Report #5087061-4
Cabergoline side effect was reported by a Physician from GERMANY on Aug 08, 2006. Male patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: antinuclear antibody increased, aortic valve sclerosis, mitral valve sclerosis, oedema peripheral, tricuspid valve sclerosis. Cabergoline dosage: unknown. Patient recovered.

Cabergoline Side Effects Report #5106231-X
Cabergoline side effect was reported by a Physician from GERMANY on Aug 30, 2005. Male patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: antinuclear antibody increased, aortic valve sclerosis, incorrect dose administered, mitral valve sclerosis, oedema peripheral, tricuspid valve sclerosis. Cabergoline dosage: unknown. Patient recovered.


Cabergoline Side Effects Report #5133242-0
Cabergoline side effect was reported by a Physician from GERMANY on Oct 05, 2006. Male patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: antinuclear antibody increased, aortic valve incompetence, aortic valve sclerosis, dilatation ventricular, mitral valve incompetence, mitral valve prolapse, mitral valve sclerosis, oedema peripheral, treatment noncompliance. Cabergoline dosage: unknown. Patient recovered.

Cabergoline Side Effects Report #4710538-5
Cabergoline side effect was reported by a Physician from GERMANY on June 27, 2005. Female patient, weighting 132.3 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, cardiac output decreased, coronary artery atherosclerosis, dyspnoea, mitral valve disease, mitral valve incompetence, mitral valve sclerosis, pleural effusion. Cabergoline dosage: DAILY, ORAL ; 6 MG (DAILY) ORAL. During the same period patient was treated with SELEGILINE, TEBONIN, NEUROPLANT, BISOPROLOL FUMARATE, GINGIUM, FUROSEMIDE, HEPARIN. Patient was hospitalized and became disabled. Patient recovered.

Cabergoline Side Effects Report #4765276-X
Cabergoline side effect was reported by a Physician from GERMANY on Aug 26, 2005. Female patient, weighting 132.3 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, coronary artery disease , mitral valve incompetence, mitral valve sclerosis, pleural effusion, pneumonia , pulmonary congestion, tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with SELEGELINE HYDROCHLORIDE, TEBONIN, NEUROPLANT, BISOPROLOL FUMARATE, GINGIUM, FUROSEMIDE, HEPARIN. Patient was hospitalized and became disabled. Patient recovered.